Vita 34 AG
XETRA:V3V

Watchlist Manager
Vita 34 AG Logo
Vita 34 AG
XETRA:V3V
Watchlist
Price: 4.06 EUR -0.98% Market Closed
Market Cap: 71.6m EUR
Have any thoughts about
Vita 34 AG?
Write Note

Wall Street
Price Targets

V3V Price Targets Summary
Vita 34 AG

Wall Street analysts forecast V3V stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for V3V is 6.43 EUR with a low forecast of 6.36 EUR and a high forecast of 6.62 EUR.

Lowest
Price Target
6.36 EUR
57% Upside
Average
Price Target
6.43 EUR
58% Upside
Highest
Price Target
6.62 EUR
63% Upside
Vita 34 AG Competitors:
Price Targets
600763
Topchoice Medical Co Inc
10% Upside
QC7
Q & M Dental Group (Singapore) Ltd
33% Upside
MD
MEDNAX Inc
23% Upside
DCGO
DocGo Inc
45% Upside
ADUS
Addus Homecare Corp
11% Upside
IDHC
Integrated Diagnostics Holdings PLC
25% Upside
4694
BML Inc
4% Upside
INFU
InfuSystem Holdings Inc
77% Upside

Revenue
Forecast

Revenue Estimate
Vita 34 AG

For the last 8 years the compound annual growth rate for Vita 34 AG's revenue is 24%. The projected CAGR for the next 3 years is 4%.

24%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vita 34 AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Vita 34 AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is V3V's stock price target?
Price Target
6.43 EUR

According to Wall Street analysts, the average 1-year price target for V3V is 6.43 EUR with a low forecast of 6.36 EUR and a high forecast of 6.62 EUR.

What is Vita 34 AG's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Vita 34 AG's revenue is 24%. The projected CAGR for the next 3 years is 4%.

Back to Top